A pair of artificial intelligence algorithms from Boston Scientific and Medtronic can be used by the NHS to monitor heart failure patients with implantable devices, but two others from Biotronik and Abbott Medical have not passed muster.The algorithms are designed to detect the early signs of worsening heart failure in people with CIEDs – pacemakers, implantable cardioverter defibrillators, and cardiac resynchronisation therapy devices – and send an alert to the care team.Updated guidance from health technology assessment (HTA) agency NICE has concluded that Boston Scientific's HeartLogic and Medtronic's TriageHF diagnostics are 'options for algorithm-based remote monitoring in people with cardiac implantable electronic devices (CIEDs) who have heart failure,' provided they are used by specialist care teams.Biotronik's HeartInsight can only be used in research studies for now, while further information is gathered, but Abbott's CorVue has been placed on the 'do not use' list as it does not gather as much information as the rival algorithms.More research is also needed on HeartLogic, TriageHF, and HeartInsight for monitoring people with CIEDs who are at risk of developing heart failure, according to NICE.The four algorithms were considered in the context of standard remote monitoring, in which devices wirelessly transmit data regularly to warn of any status changes.

NHS可以使用波士顿科学公司（Boston Scientific）和美敦力公司（Medtronic）的一对人工智能算法来监测植入设备的心力衰竭患者，但Biotronik和Abbott Medical的另外两个算法尚未通过测试。这些算法旨在检测CIED患者（起搏器、植入式心脏复律除颤器和心脏再同步治疗设备）心力衰竭恶化的早期迹象，并向护理团队发出警报。健康技术评估（HTA）机构NICE的最新指南得出结论，波士顿科学公司（Boston Scientific）的HeartLogic和美敦力（Medtronic）的TriageHF诊断是“对患有心力衰竭的心脏植入式电子设备（CIED）患者进行基于算法的远程监测的选择”，前提是这些设备由专业护理团队使用。Biotronik的HeartInsight目前只能用于研究，同时还可以收集更多信息，但雅培的CorVue已被列入“不使用”列表，因为它收集的信息不如竞争对手的算法那么多。NICE表示，还需要对HeartLogic、TriageHF和HeartInsight进行更多研究，以监测有患心力衰竭风险的CIED患者。这四种算法是在标准远程监控的背景下考虑的，其中设备定期无线传输数据以警告任何状态变化。

The AIs are layered over that data to try to spot changes more quickly and efficiently.NICE's expert committee notes that wider availability of algorithm-based remote monitoring may allow greater access to care for people who are less able to attend in-person appointments.'Evidence for HeartLogic and TriageHF shows that they can detect the signs of worsening heart failure that could lead to hospitalisation or.

人工智能对这些数据进行分层，以试图更快、更有效地发现变化。NICE的专家委员会指出，基于算法的远程监控的广泛应用可能会使那些无法亲自预约的人获得更多的护理。”HeartLogic和TriageHF的证据表明，他们可以检测到可能导致住院或住院的心力衰竭恶化的迹象。